• BOIRON Nux Vomica Compose Granulos, 1 tubo

BOIRON Nux Vomica Compose Granules, 1 tube

SKU526213

Homeopathic medicine traditionally used for the treatment of dyspeptic problems of gastric origin.

We are pharmacists
Consult us with any questions about the medication.
Regular price €7,95
Sale price €7,95 Regular price €7,95
You are saving: -€0,00
BOIRON Nux Vomica Compose Granulos, 1 tubo
BOIRON Nux Vomica Compose Granules, 1 tube
Regular price €7,95
Sale price €7,95 Regular price €7,95
You are saving: -€0,00

1. NAME OF THE MEDICINAL PRODUCT

NUX VOMICA COMPOSÉ BOIRON granules.

2. COMPOSITION of NUX VOMICA COMPOSÉ BOIRON

Strychnos nux vomica 3 CH, Bryonia 3 CH, Argenti nitras 3 CH, Condurango 3 CH, Abies nigra 3 CH, Robinia pseudo acacia 3 CH, Solidago virga aurea 3 DH a.a. Excipients: sucrose and lactose q.s. 1 tube of 4 g of granules.

3. PHARMACEUTICAL FORMS

1 tube of 4 g granules.

4. CLINICAL DATA.

4.1 Therapeutic indications: Homeopathic medicinal product traditionally used in the treatment of dyspeptic problems of gastric origin.

4.2 Dosage and method of administration of NUX VOMICA COMPOSÉ BOIRON: To remove the granules from the tube, remove the tab on the label, turn the tube upside down and rotate the granule counter until the desired number of granules is obtained. Dissolve 5 granules under the tongue 3 times a day. Oral use. Sublingual absorption

4.3 Contraindications: None described.

4.4 Special warnings and precautions for use. Not described. Warnings on excipients: : 5 granules contain 0.04 g lactose. Patients with hereditary galactose intolerance, Lapp lactase insufficiency (insufficiency observed in certain Lapland populations) or glucose or galactose malabsorption should not take this medicinal product. 5 granules contain 0.21 g sucrose. Patients with hereditary fructose intolerance, glucose or galactose malabsorption, or sucrase-isomaltase insufficiency should not take this medicinal product.

4.5 Interaction with other medicinal products and other forms of interaction: Not described.

4.6 Pregnancy and lactation: There are no specific studies in pregnant women or during lactation.

4.7 Effects on ability to drive and use machines: NUX VOMICA COMPOSÉ BOIRON does not affect the ability to drive or use machines.

4.8 Adverse reactions: No adverse reactions have been reported. It is important to report suspected adverse reactions to the medicinal product after authorisation. This allows continued monitoring of the benefit/risk ratio of the medicinal product. Healthcare professionals are encouraged to report suspected adverse reactions through the Spanish Pharmacovigilance System for Medicinal Products for Human Use: https://www.notificaram.es.

4.9 Overdosage: No cases of overdosage have been reported.

5. PHARMACOLOGICAL PROPERTIES

The properties of this medicinal product, for the proposed indications, are described in the homeopathic materia medica.

6. PHARMACEUTICAL PARTICULARS

6.1 List of excipients: sucrose and lactose.

6.2 Incompatibilities: not described.

6.3 Shelf life: 5 years.

6.4 Special storage precautions: Keep below 25°C and protect from moisture.

6.5 Nature and contents of container: 1 x 4 gram translucent coloured polypropylene tube.

6.6 Special precautions for disposal: The Integrated System for the Management and Collection of Pharmaceutical Packaging (SIGRE) should be used for disposal.

7. MARKETING AUTHORISATION HOLDER

Laboratorios Boiron SIH, Avenida Valdelaparra, 27 - 28108 Alcobendas - Madrid.

8. MANUFACTURER BOIRON

2 avenue de l'Ouest Lyonnais - 69510 Messimy - FRANCE

9. AUTHORISATION

This medicinal product is marketed in accordance with the 6th Transitional Provision of Royal Decree 1345/2007.

10. CONDITIONS OF DISPENSING

Without medical prescription, not reimbursable by the National Health System. Information reserved for healthcare professionals.

Rev: 28/05/2013

Ficha técnica
Ver medicamento en el Centro de informaciónonline de medicamentos de la AEMPS – CIMA